Jusef Erabi Set to Join Millwall FC from Hammarby IF
Jusef Erabi is on the brink of transferring from Hammarby IF to Millwall FC for around 50 million kronor.
Key Points
- • Erabi's transfer fee is reported to be around 50 million kronor.
- • Millwall has agreed with Hammarby on the transfer terms.
- • Erabi is expected to undergo a medical exam in London soon.
- • Interest from Genk is no longer relevant, with Erabi favoring Millwall.
In a significant transfer move, Swedish forward Jusef Erabi is poised to leave Hammarby IF for English club Millwall FC. Both clubs have reached a financial agreement reportedly valued at around 50 million kronor (approximately five million euros), making this a notable transaction in Swedish football.
Negotiations between Hammarby and Millwall have progressed rapidly, with multiple sources confirming that Erabi is expected to fly to London for a medical examination and to finalize his contract. Hammarby's representative, Hjelmberg, has acknowledged the ongoing discussions regarding Erabi's transfer, indicating they are in the final stages of negotiations, also mentioning another unnamed player referred to as 'Shaq'. Earlier interest from Welsh club Swansea City, which made two unsuccessful bids for Erabi, has been overshadowed by Millwall's decisive offer, and as of now, the Belgian club Genk’s interest is considered inactive, with Erabi focusing on the English opportunity.
Adding to the excitement, renowned transfer journalist Fabrizio Romano recently reported that Erabi had been deliberating between Millwall and Genk but has now settled on the Championship side. Hammarby, which has subsequently removed Erabi from training, highlights the seriousness of the negotiations taking place.
This move marks a significant moment for Erabi's career as he transitions from the Allsvenskan league to England's Championship, a step that is expected to elevate his profile further on an international stage. As of now, fans and analysts await the official announcement of the transfer and any further developments in the coming days.